Although it could be suggested that the reduction observed in all cause mortality with β blockers is attributable to their cardiovascular effects, similar benefits were seen in reducing deaths from COPD and deaths from myocardial infarction, although some hazard ratios within groups failed to reach statistical significance.
← all excerpts
Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
1
—
—